[1]
Saggia, C. 2018. HER2-positive breast cancer with brain metastasis, long responder to lapatinib therapy: Carcinoma mammario HER2-positivo con metastasi cerebrali, lungorispondente alla terapia con lapatinib. AboutOpen. 4, 1 (Jun. 2018), 59–61. DOI:https://doi.org/10.19156/abtpn.2018.0042.